Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04995900
Other study ID # 291276657
Secondary ID 1180282
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2022
Est. completion date March 31, 2023

Study information

Verified date June 2023
Source Monash University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to evaluate whether providing a targeted heart health education campaign to regions at high risk of heart attacks will improve ACS patient's symptom recognition and response. The intervention will be will be evaluated according to a cluster randomized, stepped wedged design. The clusters are eight local government areas (LGAs) in Victoria, Australia. The main primary outcome will be assessed in consecutive patients presenting to emergency departments from the six LGAs throughout the study period with an ED diagnoses of acute coronary syndrome.


Description:

Primary objectives: To determine if targeted heart health education will: 1. Increase ambulance use in ACS patients (main primary outcome); 2. Decrease patient and prehospital delay times in ACS patients; 3. Increase awareness of personal cardiovascular risk and associated factors in adult community members; and 4. Increase cardiovascular knowledge and confidence to act to heart attack warning signs in adult community members. Secondary objectives 1. To determine if targeted heart health education: 2. Reduces the incidence of out-of-hospital cardiac arrest; 3. Improves survival in OHCA patients; 4. Improves survival in ACS patients; 5. Improves survival and ACS patients; 6. Increases presentations to ED for ACS and unspecified chest pain; and 7. Increases the rates of calls to ambulance for chest pain and non-chest pain. 8. Increases the rate of Heart Health Checks. Intervention: To meet the objectives of the study, we will employ HM coordinators for each of the eight high-risk LGAs to organise and deliver our HM education program using HM materials and Partner resources. Design: The stepped-wedge design is a uni-directional cross-over design - where the randomisation element is when the cluster crosses-over to the intervention following a control period. Over the 16-month study period, the eight LGAs will move into the intervention phase at two month intervals. As four LGAs are in close proximity, these LGAs will switch from control to intervention periods at the same time to avoid possible contamination.


Recruitment information / eligibility

Status Completed
Enrollment 2240
Est. completion date March 31, 2023
Est. primary completion date March 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Adult residents of the eight local government areas - Exclusion Criteria: Adults not residing in the eight local government areas. -

Study Design


Intervention

Other:
Community education
Heart Matters coordinators will deliver heart health education to the community using HM materials and Partner resources.

Locations

Country Name City State
Australia Victorian LGAs Melbourne Please Select

Sponsors (4)

Lead Sponsor Collaborator
Monash University Ambulance Victoria, Department of Health, Victorian Government, National Heart Foundation, Australia

Country where clinical trial is conducted

Australia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ambulance use for ACS The proportion of ACS patients that present to ED by ambulance. 16 months
Secondary Median ACS patient delay time The median ACS patients delay time (time from symptom onset to decision to seek medical attention). 16 months
Secondary ACS patient delay time <60 minutes The proportion of ACS patients with patient delay times <60 minutes 16 months
Secondary Median ACS patient prehospital delay time The median ACS patient prehospital delay time (time from symptom onset to arrival at hospital). 16 months
Secondary ACS patients prehospital delay times <120 minutes The proportion of ACS patients with prehospital delay times <120 minutes 16 months
Secondary Awareness of own risk of heart attack The proportion of adult members of the community who are aware of their own risk of heart attack. 0-2 months and 6-8 months
Secondary Awareness of heart attack as a leading cause of death The proportion of adult members of the community who identify heart disease a leading cause of death 0-2 months and 6-8 months
Secondary Awareness of heart attack risk factors The proportion of adult members of the community who identify cardiovascular risk factors 0-2 months and 6-8 months
Secondary Number of correctly named heart attack risk factors The number of correctly named cardiovascular risk factors by adult members of the community 0-2 months and 6-8 months
Secondary Awareness of heart attack signs and symptoms The proportion of adult members of the community aware of heart attack symptoms 0-2 months and 6-8 months
Secondary Number of correctly named heart attack signs and symptoms The number of correctly named ACS symptoms by adult members of the community 0-2 months and 6-8 months
Secondary Confidence in knowing how to act The proportion adult members of the community who are confident about what they would do if experiencing a heart attack 0-2 months and 6-8 months
Secondary Ambulance use in scenarios The proportion adult members of the community who correctly state they would call an ambulance for two heart attack scenarios. 0-2 months and 6-8 months
Secondary Rates of Heart Health Checks Rates of Medicare claims for General Practitioner (GP) Heart Health Checks 16 months
Secondary Rates of ACS ED presentations The rates of ED presentations that are ACS 16 months
Secondary Rates of unspecified chest pain ED presentations Rates of ED presentations that are unspecified chest pain 16 months
Secondary ACS ED presentations via GPs Proportion of ACS ED presentations via General Practitioners 16 months
Secondary Rates of ACS survival The proportion of ACS patients surviving to hospital discharge 16 months
Secondary Incidence of OHCA incidence of out-of-hospital cardiac arrest 16 months
Secondary Rates of OHCA Rates out-of-hospital cardiac arrest survival 16 months
Secondary Calls to ambulance for chest pain Proportion of chest pain (event type 10) calls to ambulance 16 months
Secondary Calls to ambulance for non- chest pain Proportion of non-chest pain emergency calls to ambulance 16 months
See also
  Status Clinical Trial Phase
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06013813 - Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI N/A
Recruiting NCT05412927 - AngelMed Guardian® System PMA Post Approval Study
Completed NCT02750579 - Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes? N/A
Completed NCT04102410 - Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients N/A
Enrolling by invitation NCT03342131 - Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome N/A
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Enrolling by invitation NCT04676100 - International CR Registry
Completed NCT03590535 - 5th Generation cTnT in ED ACS
Recruiting NCT05437900 - INSIGHTFUL-FFR Clinical Trial Phase 4
Completed NCT05551429 - Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
Terminated NCT04316481 - IDE-ALERTS Continued Access Study N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Not yet recruiting NCT04852146 - Electronic Feedback for Data Restitution and Valorization to the Emergency Teams in Aquitaine.
Active, not recruiting NCT02892903 - In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes? N/A
Not yet recruiting NCT02871622 - BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM N/A
Completed NCT04077229 - Piloting Text Messages to Promote Positive Affect and Physical Activity N/A
Completed NCT02944123 - Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) Phase 3
Active, not recruiting NCT02922140 - The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit N/A
Completed NCT02673437 - Rivaroxaban ACS Specialist Cohort Event Monitoring Study